TABLE 1

Group Comparison Results of Clinical Variables and 11C-DTBZ PET Variables in Group of Patients (n = 17) with Either Normal or Partial, Mild Cardiac Denervation (Global SEP ≥ 100) Versus Group of Patients (n = 22) with More Extensive Cardiac Denervation (Global SEP ≤ 150)

VariableNormal or relatively preserved sympathic cardiac innervation (n = 17)More extensive sympathetic cardiac denervation (n = 22)Student t test
Age63.7 ± 5.861.0 ± 5.91.3994 (P = 0.0850)
MoCa score25.63 ± 1.6926.84 ± 1.921.55 (P = 0.14)
Duration of motor disease (y)4.3 ± 3.25.1 ± 3.1−0.8347 (P = 0.2046)
Hoehn and Yahr stage2.23 ± 0.322.18 ± 0.420.3776 (P = 0.3541)
Nonmotor experiences of daily living5.24 ± 4.426.54 ± 5.51−0.8005 (P = 0.7857)
UPDRS scores
 Motor UPDRS scores27.74 ± 7.3028.86 ± 13.412−0.3122 (P = 0.6217)
 UPDRS tremor scores4.13 ± 43.103.39 ± 2.710.7410 (P = 0.2321)
 UPDRS PIGD scores5.43 ± 3.066.08 ± 3.21−0.5943 (P = 0.7218)
Fatigue severity scale22.75 ± 12.8632.16 ± 13.181.71 (P = 0.10)
Epworth sleepiness scale6.35 ± 2.788.29 ± 4.27−1.6088 (P = 0.0582)
Striatal 11C-DTBZ DVR2.04 ± 0.271.91 ± 0.301.3043 (P = 0.1002)
Putamen 11C-DTBZ DVR1.90 ± 0.251.78 ± 0.301.3764 (P = 0.0886)
Caudate nucleus 11C-DTBZ DVR2.00 ± 0.331.88 ± 0.331.0882 (P = 0.1419)
  • MoCa = Montreal Cognitive Assessment; UPDRS = Unified Parkinson Disease Rating Scale; PIGD = postural instability and gait difficulties; DVR = distribution volume ratio.

  • Data in parentheses are significance levels.